Enliven Therapeutics, Inc.
ELVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001672619
In the last 90 days, Enliven Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 214 institutions reported holding it in 13F filings for Q2 2026, worth $4.06B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Enliven Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −9 vs. Q1 2021
- Shares held
- 10.9M
- −78.3K (−0.7%) vs. Q1 2021
- Total value
- $86.3M
- −$6.56M (−7.1%) vs. Q1 2021
- New holders
- 7
- 8 more added
- Sold out
- 16
- 12 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $4.06B |
| Q1 2026 | 171 | $2.43B |
| Q4 2025 | 126 | $960.9M |
| Q3 2025 | 134 | $1.22B |
| Q2 2025 | 125 | $1.19B |
| Q1 2025 | 122 | $983.9M |
| Q4 2024 | 114 | $1.12B |
| Q3 2024 | 102 | $1.22B |
| Q2 2024 | 93 | $1.13B |
| Q1 2024 | 74 | $780.8M |
| Q4 2023 | 62 | $539.8M |
| Q3 2023 | 61 | $533.8M |
| Q2 2023 | 63 | $797.9M |
| Q1 2023 | 45 | $735.0M |
| Q4 2022 | 36 | $74.7M |
| Q3 2022 | 31 | $18.8M |
| Q2 2022 | 26 | $13.1M |
| Q1 2022 | 31 | $26.2M |
| Q4 2021 | 35 | $33.6M |
| Q3 2021 | 38 | $62.5M |
| Q2 2021 | 31 | $86.3M |
| Q1 2021 | 40 | $92.9M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Enliven Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 30 | $0 | 0.00% | −2,307−98.7% | Reduced |
| Tower Research Capital LLC (TRC) | 6 | $0 | 0.00% | −1,786−99.7% | Reduced |
| New York State Common Retirement Fund | 64 | $1.00K | 0.00% | −6,336−99.0% | Reduced |
| Panagora Asset Management Inc | 116 | $1.00K | 0.00% | −6−4.9% | Reduced |
| Royal Bank of Canada | 1,994 | $16.0K | 0.00% | +1,154+137.4% | Added |
| UBS Group AG | 2,143 | $17.0K | 0.00% | +504+30.8% | Added |
| JPMorgan Chase & Co | 10,091 | $80.0K | 0.00% | −10,919−52.0% | Reduced |
| Goldman Sachs Group Inc | 10,546 | $83.0K | 0.00% | −2,198−17.2% | Reduced |
| Occudo Quantitative Strategies LP | 10,496 | $83.0K | 0.01% | +10,496 | New |
| Advisory Services Network, LLC | 12,680 | $100.0K | 0.00% | +1,000+8.6% | Added |
| Jacobs Levy Equity Management, Inc | 13,794 | $109.0K | 0.00% | 00.0% | Unchanged |
| Altfest L J & Co Inc | 15,234 | $120.0K | 0.03% | +295+2.0% | Added |
| Bank of America Corp | 15,638 | $124.0K | 0.00% | −31,349−66.7% | Reduced |
| Charles Schwab Investment Management Inc | 18,284 | $145.0K | 0.00% | −15,466−45.8% | Reduced |
| State Street Corp | 21,198 | $167.0K | 0.00% | −89,387−80.8% | Reduced |
| Deutsche Bank AG | 21,503 | $170.0K | 0.00% | +10,122+88.9% | Added |
| HRT Financial LP | 21,915 | $173.0K | 0.00% | +21,915 | New |
| Ergoteles LLC | 31,546 | $249.0K | 0.01% | +31,546 | New |
| Great Valley Advisor Group, Inc. | 32,211 | $254.0K | 0.02% | +32,211 | New |
| Millennium Management LLC | 34,863 | $275.0K | 0.00% | +17,282+98.3% | Added |
| Tibra Equities Europe Ltd | 37,500 | $296.0K | 0.09% | +37,500 | New |
| Renaissance Technologies LLC | 39,768 | $314.0K | 0.00% | +39,768 | New |
| Geode Capital Management, LLC | 51,473 | $406.0K | 0.00% | −53,471−51.0% | Reduced |
| BlackRock Inc. | 77,674 | $613.0K | 0.00% | −378,694−83.0% | Reduced |
| Vanguard Group Inc | 191,411 | $1.51M | 0.00% | −38,698−16.8% | Reduced |
| Russell Investments Group, Ltd. | 193,904 | $1.53M | 0.00% | +193,904 | New |
| Ra Capital Management, L.P. | 248,804 | $1.97M | 0.03% | 00.0% | Unchanged |
| Morgan Stanley | 429,033 | $3.39M | 0.00% | +106,705+33.1% | Added |
| FMR LLC | 2,645,931 | $20.9M | 0.00% | +399,389+17.8% | Added |
| OrbiMed Advisors LLC | 2,719,902 | $21.5M | 0.22% | 00.0% | Unchanged |
| NEA Management Company, LLC | 4,017,170 | $31.7M | 0.41% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −79,465−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −77,857−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −50,927−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −33,703−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −18,149−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −16,500−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −15,979−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −15,781−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −14,913−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −11,578−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −4,462−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −976−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −508−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −437−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −236−100.0% | Sold out |